text_1: Metastatic colorectal cancer treated with a single agent fluoropyrimidines resulted in reduced efficacy and lower quality of life when compared with oxaliplatin-based chemotherapy in elderly patients.
text_2: Baseline clinical and CHA data were modelled against outcomes with a novel composite measure, overall treatment utility (OTU).